Cite
Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts
MLA
Gary D. Lopaschuk, et al. “Glucagon and a Glucagon-GLP-1 Dual-Agonist Increases Cardiac Performance with Different Metabolic Effects in Insulin-Resistant Hearts.” British Journal of Pharmacology, vol. 165, Mar. 2012, pp. 2736–48. EBSCOhost, https://doi.org/10.1111/j.1476-5381.2011.01714.x.
APA
Gary D. Lopaschuk, Spencer D. Proctor, Lene Nygaard Axelsen, Henrik Duelund Pedersen, Niels-Henrik Holstein-Rathlou, Eddi Meier, Ditte Riber, Anne Louise Kjølbye, Wendy Keung, & Joergen Soeberg Petersen. (2012). Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts. British Journal of Pharmacology, 165, 2736–2748. https://doi.org/10.1111/j.1476-5381.2011.01714.x
Chicago
Gary D. Lopaschuk, Spencer D. Proctor, Lene Nygaard Axelsen, Henrik Duelund Pedersen, Niels-Henrik Holstein-Rathlou, Eddi Meier, Ditte Riber, Anne Louise Kjølbye, Wendy Keung, and Joergen Soeberg Petersen. 2012. “Glucagon and a Glucagon-GLP-1 Dual-Agonist Increases Cardiac Performance with Different Metabolic Effects in Insulin-Resistant Hearts.” British Journal of Pharmacology 165 (March): 2736–48. doi:10.1111/j.1476-5381.2011.01714.x.